Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pretomanid-resistant tuberculosis.
Koehler N, Andres S, Merker M, Dreyer V, John A, Kuhns M, Krieger D, Choong E, Verougstraete N, Zur Wiesch PA, Wicha SG, König C, Kalsdorf B, Sanchez Carballo PM, Schaub D, Werngren J, Schön T, Peloquin CA, Schönfeld N, Verstraete AG, Decosterd LA, Aarnoutse R, Niemann S, Maurer FP, Lange C. Koehler N, et al. Among authors: choong e. J Infect. 2023 May;86(5):520-524. doi: 10.1016/j.jinf.2023.01.039. Epub 2023 Feb 2. J Infect. 2023. PMID: 36738862 No abstract available.
Development and validation of a multiplex UHPLC-MS/MS assay with stable isotopic internal standards for the monitoring of the plasma concentrations of the antiretroviral drugs bictegravir, cabotegravir, doravirine, and rilpivirine in people living with HIV.
Courlet P, Alves Saldanha S, Cavassini M, Marzolini C, Choong E, Csajka C, Günthard HF, André P, Buclin T, Desfontaine V, Decosterd LA. Courlet P, et al. Among authors: choong e. J Mass Spectrom. 2020 Jun;55(6):e4506. doi: 10.1002/jms.4506. Epub 2020 Mar 11. J Mass Spectrom. 2020. PMID: 32160389 Free PMC article.
A battery of tandem mass spectrometry assays with stable isotope-dilution for the quantification of 15 anti-tuberculosis drugs and two metabolites in patients with susceptible-, multidrug-resistant- and extensively drug-resistant tuberculosis.
Mercier T, Desfontaine V, Cruchon S, Da Silva Pereira Clara JA, Briki M, Mazza-Stalder J, Kajkus A, Burger R, Suttels V, Buclin T, Opota O, Koehler N, Sanchez Carballo PM, Lange C, André P, Decosterd LA, Choong E. Mercier T, et al. Among authors: choong e. J Chromatogr B Analyt Technol Biomed Life Sci. 2022 Nov 15;1211:123456. doi: 10.1016/j.jchromb.2022.123456. Epub 2022 Sep 20. J Chromatogr B Analyt Technol Biomed Life Sci. 2022. PMID: 36240540
A Single-Run HPLC-MS Multiplex Assay for Therapeutic Drug Monitoring of Relevant First- and Second-Line Antibiotics in the Treatment of Drug-Resistant Tuberculosis.
Köhler N, Karaköse H, Grobbel HP, Hillemann D, Andres S, König C, Kalsdorf B, Brehm TT, Böttcher L, Friesen I, Hoffmann H, Strelec D, Schaub D, Peloquin CA, Schmiedel S, Decosterd LA, Choong E, Wicha SG, Aarnoutse RE, Lange C, Sánchez Carballo PM. Köhler N, et al. Among authors: choong e. Pharmaceutics. 2023 Oct 27;15(11):2543. doi: 10.3390/pharmaceutics15112543. Pharmaceutics. 2023. PMID: 38004523 Free PMC article.
Oritavancin use in patients with recurrent bone infections by methicillin-resistant Staphylococcus aureus with monitoring of concentrations.
Bongiovanni M, Thoueille P, Barda B, Mercier T, Marzolini C, Ramponi N, Choong E, Cantù M, Decosterd LA, Bernasconi E. Bongiovanni M, et al. Among authors: choong e. Eur J Clin Microbiol Infect Dis. 2024 Jul;43(7):1503-1504. doi: 10.1007/s10096-024-04844-5. Epub 2024 May 14. Eur J Clin Microbiol Infect Dis. 2024. PMID: 38740656 No abstract available.
68 results